| Jun 21 |
Defying the Norms: 3 High P/E Stocks With Room to Run
|
| Jun 21 |
5 Things to Know Before the Stock Market Opens
|
| Jun 21 |
Strength Seen in Gilead (GILD): Can Its 8.5% Jump Turn into More Strength?
|
| Jun 21 |
CarMax, Gilead and Sarepta rise premarket; Nvidia falls
|
| Jun 20 |
Housing trends, HPE CEO on Nvidia partnership: Market Domination
|
| Jun 20 |
S&P 500 Gains and Losses Today: Index Dips After Briefly Crossing 5,500
|
| Jun 20 |
Gilead’s Twice-Yearly Shot Prevents HIV. Where the Stock Is Headed.
|
| Jun 20 |
US Equities Markets Close Mixed Thursday as Markets Parse Latest Economic Data
|
| Jun 20 |
Gilead Sciences stock jumps on HIV treatment trial success
|
| Jun 20 |
Gilead Flashes A Bullish Sign After HIV Drug Proves 100% Effective
|
